trending Market Intelligence /marketintelligence/en/news-insights/trending/CMsfuVRoP7d98Uro-oSK1Q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Fresenius' dialysis system receives US FDA breakthrough-device tag

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Fresenius' dialysis system receives US FDA breakthrough-device tag

Fresenius Medical Care AG & Co. KGaA's dialysis system that prevents blood clotting without the use of blood-thinning drugs has received the U.S. Food and Drug Administration's breakthrough-device designation.

The dialysis system is manufactured using Endexo, a polymer that inhibits adhesion of proteins and platelets to the device surface and reduces clot risk. The system also uses Citrasate as a dialysate, a solution of pure water, electrolytes and salts that pulls toxins from the blood.

Fresenius' unit Fresenius Medical Care North America Holdings LP acquired an exclusive worldwide license from Interface Biologics Inc. to use Endexo technology to manufacture various components of its dialysis system.

The U.S. regulator granted breakthrough device designation to Fresenius' computer-assisted ultrafiltration control software in March.

The breakthrough designation speeds up the development and review process for technologies that provide more effective treatment or diagnosis of life-threatening or debilitating diseases.